Royce & Associates LP Cuts Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Royce & Associates LP trimmed its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 15.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 643,256 shares of the company's stock after selling 114,812 shares during the period. Royce & Associates LP owned approximately 1.41% of Azenta worth $22,282,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of AZTA. Wakefield Asset Management LLLP purchased a new position in shares of Azenta during the 1st quarter valued at $861,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Azenta during the 1st quarter valued at $1,890,000. Y Intercept Hong Kong Ltd grew its position in Azenta by 16.0% in the first quarter. Y Intercept Hong Kong Ltd now owns 25,075 shares of the company's stock worth $869,000 after acquiring an additional 3,465 shares in the last quarter. Allianz Asset Management GmbH purchased a new position in Azenta in the first quarter worth $301,000. Finally, Segall Bryant & Hamill LLC grew its position in Azenta by 11.1% in the first quarter. Segall Bryant & Hamill LLC now owns 320,137 shares of the company's stock worth $11,090,000 after acquiring an additional 32,037 shares in the last quarter. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Stock Up 1.4%

Shares of NASDAQ:AZTA traded up $0.47 during midday trading on Friday, hitting $34.43. 437,863 shares of the stock traded hands, compared to its average volume of 952,662. The stock has a market capitalization of $1.58 billion, a PE ratio of -24.77 and a beta of 1.64. The business's 50 day moving average is $30.35 and its two-hundred day moving average is $35.93. Azenta, Inc. has a one year low of $23.91 and a one year high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. During the same quarter in the prior year, the company earned $0.06 earnings per share. Azenta's quarterly revenue was up 5.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

AZTA has been the subject of several research reports. Needham & Company LLC cut their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Stephens started coverage on shares of Azenta in a research note on Tuesday. They issued an "equal weight" rating and a $35.00 price target for the company. Finally, Evercore ISI boosted their price target on shares of Azenta from $29.00 to $35.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.